Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
MMWR Morb Mortal Wkly Rep ; 72(41): 1108-1114, 2023 Oct 13.
Artigo em Inglês | MEDLINE | ID: mdl-37824430

RESUMO

During the 2022-23 influenza season, early increases in influenza activity, co-circulation of influenza with other respiratory viruses, and high influenza-associated hospitalization rates, particularly among children and adolescents, were observed. This report describes the 2022-23 influenza season among children and adolescents aged <18 years, including the seasonal severity assessment; estimates of U.S. influenza-associated medical visits, hospitalizations, and deaths; and characteristics of influenza-associated hospitalizations. The 2022-23 influenza season had high severity among children and adolescents compared with thresholds based on previous seasons' influenza-associated outpatient visits, hospitalization rates, and deaths. Nationally, the incidences of influenza-associated outpatient visits and hospitalization for the 2022-23 season were similar for children aged <5 years and higher for children and adolescents aged 5-17 years compared with previous seasons. Peak influenza-associated outpatient and hospitalization activity occurred in late November and early December. Among children and adolescents hospitalized with influenza during the 2022-23 season in hospitals participating in the Influenza Hospitalization Surveillance Network, a lower proportion were vaccinated (18.3%) compared with previous seasons (35.8%-41.8%). Early influenza circulation, before many children and adolescents had been vaccinated, might have contributed to the high hospitalization rates during the 2022-23 season. Among symptomatic hospitalized patients, receipt of influenza antiviral treatment (64.9%) was lower than during pre-COVID-19 pandemic seasons (80.8%-87.1%). CDC recommends that all persons aged ≥6 months without contraindications should receive the annual influenza vaccine, ideally by the end of October.


Assuntos
Vacinas contra Influenza , Influenza Humana , Gravidade do Paciente , Adolescente , Criança , Humanos , Lactente , COVID-19/epidemiologia , Hospitalização , Incidência , Influenza Humana/prevenção & controle , Pandemias , Estações do Ano , Estados Unidos/epidemiologia
2.
JMIR Public Health Surveill ; 8(6): e34296, 2022 06 02.
Artigo em Inglês | MEDLINE | ID: mdl-35452402

RESUMO

BACKGROUND: In the United States, COVID-19 is a nationally notifiable disease, meaning cases and hospitalizations are reported by states to the Centers for Disease Control and Prevention (CDC). Identifying and reporting every case from every facility in the United States may not be feasible in the long term. Creating sustainable methods for estimating the burden of COVID-19 from established sentinel surveillance systems is becoming more important. OBJECTIVE: We aimed to provide a method leveraging surveillance data to create a long-term solution to estimate monthly rates of hospitalizations for COVID-19. METHODS: We estimated monthly hospitalization rates for COVID-19 from May 2020 through April 2021 for the 50 states using surveillance data from the COVID-19-Associated Hospitalization Surveillance Network (COVID-NET) and a Bayesian hierarchical model for extrapolation. Hospitalization rates were calculated from patients hospitalized with a lab-confirmed SARS-CoV-2 test during or within 14 days before admission. We created a model for 6 age groups (0-17, 18-49, 50-64, 65-74, 75-84, and ≥85 years) separately. We identified covariates from multiple data sources that varied by age, state, and month and performed covariate selection for each age group based on 2 methods, Least Absolute Shrinkage and Selection Operator (LASSO) and spike and slab selection methods. We validated our method by checking the sensitivity of model estimates to covariate selection and model extrapolation as well as comparing our results to external data. RESULTS: We estimated 3,583,100 (90% credible interval [CrI] 3,250,500-3,945,400) hospitalizations for a cumulative incidence of 1093.9 (992.4-1204.6) hospitalizations per 100,000 population with COVID-19 in the United States from May 2020 through April 2021. Cumulative incidence varied from 359 to 1856 per 100,000 between states. The age group with the highest cumulative incidence was those aged ≥85 years (5575.6; 90% CrI 5066.4-6133.7). The monthly hospitalization rate was highest in December (183.7; 90% CrI 154.3-217.4). Our monthly estimates by state showed variations in magnitudes of peak rates, number of peaks, and timing of peaks between states. CONCLUSIONS: Our novel approach to estimate hospitalizations for COVID-19 has potential to provide sustainable estimates for monitoring COVID-19 burden as well as a flexible framework leveraging surveillance data.


Assuntos
COVID-19 , Teorema de Bayes , COVID-19/epidemiologia , Hospitalização , Humanos , Incidência , Recém-Nascido , SARS-CoV-2 , Estados Unidos/epidemiologia
3.
MMWR Morb Mortal Wkly Rep ; 71(13): 489-494, 2022 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-35358168

RESUMO

COVID-19 testing provides information regarding exposure and transmission risks, guides preventative measures (e.g., if and when to start and end isolation and quarantine), identifies opportunities for appropriate treatments, and helps assess disease prevalence (1). At-home rapid COVID-19 antigen tests (at-home tests) are a convenient and accessible alternative to laboratory-based diagnostic nucleic acid amplification tests (NAATs) for SARS-CoV-2, the virus that causes COVID-19 (2-4). With the emergence of the SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variants in 2021, demand for at-home tests increased† (5). At-home tests are commonly used for school- or employer-mandated testing and for confirmation of SARS-CoV-2 infection in a COVID-19-like illness or following exposure (6). Mandated COVID-19 reporting requirements omit at-home tests, and there are no standard processes for test takers or manufacturers to share results with appropriate health officials (2). Therefore, with increased COVID-19 at-home test use, laboratory-based reporting systems might increasingly underreport the actual incidence of infection. Data from a cross-sectional, nonprobability-based online survey (August 23, 2021-March 12, 2022) of U.S. adults aged ≥18 years were used to estimate self-reported at-home test use over time, and by demographic characteristics, geography, symptoms/syndromes, and reasons for testing. From the Delta-predominant period (August 23-December 11, 2021) to the Omicron-predominant period (December 19, 2021-March 12, 2022)§ (7), at-home test use among respondents with self-reported COVID-19-like illness¶ more than tripled from 5.7% to 20.1%. The two most commonly reported reasons for testing among persons who used an at-home test were COVID-19 exposure (39.4%) and COVID-19-like symptoms (28.9%). At-home test use differed by race (e.g., self-identified as White [5.9%] versus self-identified as Black [2.8%]), age (adults aged 30-39 years [6.4%] versus adults aged ≥75 years [3.6%]), household income (>$150,000 [9.5%] versus $50,000-$74,999 [4.7%]), education (postgraduate degree [8.4%] versus high school or less [3.5%]), and geography (New England division [9.6%] versus West South Central division [3.7%]). COVID-19 testing, including at-home tests, along with prevention measures, such as quarantine and isolation when warranted, wearing a well-fitted mask when recommended after a positive test or known exposure, and staying up to date with vaccination,** can help reduce the spread of COVID-19. Further, providing reliable and low-cost or free at-home test kits to underserved populations with otherwise limited access to COVID-19 testing could assist with continued prevention efforts.


Assuntos
COVID-19 , Adolescente , Adulto , Idoso , COVID-19/diagnóstico , COVID-19/epidemiologia , COVID-19/prevenção & controle , Teste para COVID-19 , Estudos Transversais , Humanos , SARS-CoV-2 , Estados Unidos/epidemiologia
4.
Artigo em Inglês | MEDLINE | ID: mdl-23679404

RESUMO

The three-dimensional jamming of neutrally buoyant monodisperse, bidisperse, and tridisperse mixtures of particles flowing through a restriction under fluid flow has been studied. During the transient initial accumulation of particles at the restriction, a low probability of a jamming event is observed, followed by a transition to a steady-state flowing backlog of particles, where the jamming probability per particle reaches a constant. Analogous to the steady-state flow in gravity-driven jams, this results in a geometric distribution describing the number of particles that discharge prior to a jamming event. We develop new models to describe the transition from an accumulation to a steady-state flow, and the jamming probability after the transition has occurred. Predictions of the behavior of the geometric distribution see the log-probability of a jam occurring proportionally to (R(2)(2)-1), where R(2) is the ratio of opening diameter to the second moment number average particle diameter. This behavior is demonstrated to apply to more general restriction shapes, and collapses for all mixture compositions for the restriction sizes tested.


Assuntos
Hidrodinâmica , Modelos Teóricos , Probabilidade
5.
Phys Rev E Stat Nonlin Soft Matter Phys ; 86(6 Pt 1): 061311, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23367936

RESUMO

The jamming of particles under flow is of critical importance in a broad range of natural and industrial settings, such as the jamming of ice in rivers, or the plugging of suspended solids in pipeline transport. Relatively few studies have been carried out on jamming of suspended particles under flow, in comparison to the many studies on jamming in gravity-driven flows that have revealed various features of the jamming process. Fluid-driven particle flows differ in several aspects from gravity-driven flows, particularly in being compatible with a range of particle concentrations and velocities. Additionally, there are fluid-particle interactions and hydrodynamic effects. To investigate particle jamming in fluid-driven flows, we have performed both experiments and computer simulations on the flow of circular particles floating over water in an open channel with a restriction. We determined the flow-rate boundary for a dilute-to-dense flow transition, similar to that seen in gravity-driven flows. The maximum particle throughput increased for larger restriction sizes consistent with a Beverloo equation form over the entire range of particle mixtures and restriction sizes. The exponent of ~3/2 in the Beverloo equation is consistent with approximately constant acceleration of grains due to fluid drag in the immediate region of the opening. We verified that the jamming probability from the dense flow gave a geometric distribution in the number of particles escaping before a jam. The probability of jamming in both experiments and simulations was found to be dependent on the ratio of channel opening to particle size, but only weakly dependent on the fluid flow velocity. Flow entrance effects were measured and observed to affect the jamming probability, and dependence on particle friction coefficient was determined from simulation. A comprehensive model for the jamming probability integrating these observations from the different flow regimes was shown to be in good agreement for experimental data on average times before jamming.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...